GTR 109470817
Bids Are Invited For The Future And Eventual Acquisition Of Medicines For Free Distribution At The Municipal Pharmacy, For Patients Served By The Sus Network, Through The Municipal Health Department.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
109470817
Tendering Authority
Subscribe to view
Tender No
016/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For The Future And Eventual Acquisition Of Medicines For Free Distribution At The Municipal Pharmacy, For Patients Served By The Sus Network, Through The Municipal Health Department.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
09-03-2026
Closed
Work Detail
Acebrophylline, Concentration:5 Mg/Ml, Pharmaceutical Form:Syrup, Acetylcysteine, Dosage:600 Mg, Indication:Powder For Oral Solution, Acetylsalicylic Acid 100 Mg - Comp, Acyclovir, Dosage:200 Mg, Ascorbic Acid, Dosage:500 Mg, 02/23/2026 - 10:54:09, 02/23/2026 - 10:57:45, Tranexamic Acid, Dosage:250 Mg, Valproic Acid, Dosage:50 Mg/Ml, Pharmaceutical Form:Syrup, Essential Fatty Acids, Composition: Compound Of Caprylic, Capric, Lauric Acids, Components:Linoleic, Soy Lecithin, Presentation:Associated With Vitamins A And E, Type:Oily Lotion, Allopurinol, Dosage:100 Mg, Alprazolam, Dosage:0, 25 Mg, 50 Mg, Dosage:1 Mg, Dosage:2 Mg, Ambroxol, Composition:Hydrochloride Salt, Concentration:3 Mg/Ml, Aminophylline, Amitriptyline Hydrochloride, Dosage:25 Mg, Amoxicillin, Concentration:500Mg, Concentration:50Mg/Ml, Presentation:Powder For Oral Suspension, Ampicillin, Concentration:50 Mg/Ml, Pharmaceutical Form:Oral Suspension, Atenolol, Atorvastatin Calcium, Dosage:10 Mg, Dosage:20 Mg, Azithromycin, Powder For Oral Suspension, Bamifylline Hydrochloride, Dosage:300 Mg, Betahistine Dihydrochloride, Concentration:24 Mg, Dosage:16 Mg, Betamethasone, Composition:Dipropionate, Presentation:Associated With Betamethasone Phosphate, Dosage:5Mg + 2Mg, Use:Injectable, Associated With Ketoconazole And Neomycin, Concentration: 0.5 Mg/G + 20 Mg/G + 1.5 Mg/G, Pharmaceutical Form: Cream, Composition: Valerate, Concentration: 1 Mg/G, Bimatoprost, 3 Mg/Ml, Presentation: Ophthalmic Solution, Biperiden, Bisacodyl, Dosage: 5 Mg, Bisoprolol Fumarate, Concentration: 1, Concentration: 10 Mg, Concentration: 2. 5 Mg, Concentration: 5 Mg, Brimonidine Tartrate, Dosage: 2 Mg/Ml, Presentation: Eye Drops, Bromazepam, Dosage: 3 Mg, Dosage: 6 Mg, Bromopride, Dosage: 4 Mg/Ml, Presentation: Drops, Bupropion Hydrochloride, Concentration:150 Mg, Additional Features: Prolonged Release, Carbamazepine, Dosage:400 Mg, Presentation:Controlled Release, Carbocisteine, Concentration:20 Mg/Ml, Lithium Carbonate, Ceftriaxone Sodium, Concentration: 1 G, Pharmaceutical Form: Powder For Injectable Solution + Lidocaine? Bottle - Br0450891, Ceftriaxone Sodium 500Mg - Powder For Injectable Solution - Bottle - Br0442703, Ketoconazole, Dosage:20 Mg/G, Pharmaceutical Form:Topical Cream, Ketoprofen, Concentration:50 Mg/Ml, Pharmaceutical Form:Injectable Solution, Dosage:50 Mg, Cyanocobalamin, Presentation: Associated With Dexamethasone, Pyridoxine And Thiamine, Dosage: 5Mg + 4Mg + 100Mg + 100Mg, Indication: Injectable, Additional Feature: Ampoule I Of Vitamins And Ampoule Ii With D, Cyclobenzaprine Hydrochloride, Cilostazol, Concentration: 100 Mg, Concentration: 50 Mg, Cimetidine, Cinnarizine, Dosage:75 Mg, Ciprofibrate, Cyproterone Acetate, Presentation:Associated With Ethinylestradiol, Dosage:2Mg + 0.035Mg, Citalopram, Clindamycin, Clobetasol, Active Ingredient:Propionate Salt, 05%, Presentation:Cream, Clomipramine, Clonazepam, Dosage:2.5 Mg/Ml, Presentation:Oral Solution - Drops, Clopidogrel, Potassium Chloride, Dosage:6%, Presentation:Oral Solution, Chlorthalidone, Codeine, Dosage:30 Mg, Paracetamol, Presentation:Associated With Codeine, Dosage:500Mg + 30Mg, Collagenase, Presentation:Associated With Chloramphenicol, 6Ui + 1%, Use:Ointment, Coumarin, Composition:Associated With Troxerutin, Concentration:15 Mg + 90 Mg, Deflazacorte, Concentration:6 Mg, Dexamethasone, Concentration:2 Mg/Ml, Pharmaceutical Form:Injectable Solution, 1 Mg/Ml, Presentation:Elixir, Dexchlorpheniramine Maleate, Composition: Associated With Betamethasone, 4 Mg + 0.05 Mg/Ml, Diazepam, Diclofenac, Presentation: Pot Salt
Key Value
Tender Value
1,546,042 - BRL
Tender Documents
Global Tender Document
827ca7d0-080b-40d8-b6ec-997487edbea3.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.